Overview
About UQ Frazer Institute
The Frazer Institute is a modern research facility where clinical and basic science converge in the translational research of cancer, immunology and skin health.
The Institute is host to over 300 researchers, students and support staff. It lays claim to global, world-changing discoveries such as the world’s first cervical cancer vaccine.
Based at the Translational Research Institute (TRI) beside the Princess Alexandra Hospital, the Frazer Institute has strong clinical interactions and world-class facilities that enable researchers to be at the forefront of their fields. Our position within the TRI allows for a much greater collaborative research environment, allowing our researchers to focus their efforts on turning their scientific discoveries into better treatments for diseases, including skin cancer and various other cancers, arthritis and other autoimmune diseases.
The Institute is host to over 300 researchers, students and support staff. It lays claim to global, world-changing discoveries such as the world’s first cervical cancer vaccine.
Based at the Translational Research Institute (TRI) beside the Princess Alexandra Hospital, the Frazer Institute has strong clinical interactions and world-class facilities that enable researchers to be at the forefront of their fields. Our position within the TRI allows for a much greater collaborative research environment, allowing our researchers to focus their efforts on turning their scientific discoveries into better treatments for diseases, including skin cancer and various other cancers, arthritis and other autoimmune diseases.